TipRanks
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
US Market
CTSO
Cytosorbents
RESEARCH TOOLSreports
Want to see CTSO full AI Analyst Report?

Cytosorbents (CTSO) Income Statement

493 Followers

Cytosorbents Income Statement

Last quarter (Q2 2026), Cytosorbents's total revenue was $9.63M, an increase of 0.17% from the same quarter last year. In Q2, Cytosorbents's net income was $-4.42M. See Cytosorbents’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 37.06M$ 35.59M$ 31.08M$ 34.69M$ 40.11M
Gross Profit
$ 26.49M$ 24.89M$ 21.95M$ 20.73M$ 29.06M
Operating Expenses
$ 40.73M$ 41.34M$ 53.90M$ 52.25M$ 51.81M
Depreciation and Amortization
$ 1.63M$ 1.74M$ 2.02M$ 882.62K$ 1.13M
EBITDA
$ -4.36M$ -19.27M$ -27.88M$ -30.00M$ -24.17M
Operating Income
$ -14.24M$ -16.45M$ -31.95M$ -31.52M$ -22.74M
Other Income/Expenses
$ 5.64M$ -5.96M$ 1.89M$ -2.38M$ -2.55M
Pretax Income
$ -8.60M$ -22.41M$ -30.06M$ -33.91M$ -25.29M
Net Income
$ -8.20M$ -20.72M$ -29.25M$ -32.81M$ -24.56M
Per Share Metrics
Basic EPS
$ -2.60$ -7.60$ -13.00$ -15.00$ -11.40
Diluted EPS
$ -2.60$ -7.60$ -13.00$ -15.00$ -11.40
Weighted Average Shares Outstanding
 3.11M 2.72M 2.23M 2.18M 2.17M
Weighted Average Shares Outstanding (Diluted)
 3.11M 2.72M 2.23M 2.18M 2.17M
Currency in USD

Cytosorbents Earnings and Revenue History